Canavesi, G., Mena, M., Zaninetta, E., Gazzola, L., Bini, T., Bo, G., et al. (2024). Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort. In Abstracts from the 16° Italian Conference on AIDS and Antiviral Research (pp.10-10) [10.1136/sextrans-icar-2024.9].

Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort

Bonfanti, P;
2024

abstract + slide
HIV
English
XVI Congresso Nazionale ICAR (Italian Conference on AIDS and Antiviral Research) - Dal 19 al 21 giugno 2024
2024
Abstracts from the 16° Italian Conference on AIDS and Antiviral Research
2024
100
S1
10
10
open
Canavesi, G., Mena, M., Zaninetta, E., Gazzola, L., Bini, T., Bo, G., et al. (2024). Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort. In Abstracts from the 16° Italian Conference on AIDS and Antiviral Research (pp.10-10) [10.1136/sextrans-icar-2024.9].
File in questo prodotto:
File Dimensione Formato  
Canavesi-2024-Sexually Transmitted Infections-VoR.pdf

accesso aperto

Descrizione: No commercial re-use. See rights and permissions. Published by BMJ.
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Altro
Dimensione 371.16 kB
Formato Adobe PDF
371.16 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/494839
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact